YORVIPAL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

YORVIPAL Trademark

Serial Number: 98006567 • Registration: 8026911

YORVIPAL is a trademark filed by Ascendis Pharma Endocrinology Division A/S on May 22, 2023. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Ascendis Pharma Endocrinology Division A/S (14 trademarks)

Hellerup 2900 , DK

Entity Type: 99

Trademark Details

Filing Date

May 22, 2023

Registration Date

November 18, 2025

Published for Opposition

March 18, 2025

Goods & Services

Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatment, patient assistance and health insurance in the field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for sharing information related to hypoparathyroidism, growth disorders, endocrine disorders and bone disorders and the treatment of hypoparathyroidism, growth disorders, endocrine disorders, bone disorders for use by patients with growth hormone disorders, hypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that coordinates the delivery of health care services between health care providers, patients and those parties responsible for the payment of health care services, namely, downloadable software that allows individuals seeking medical education, information and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, downloadable software that enables health care providers to monitor patients, communicate clinical information relevant to a patient's care, provide and exchange information concerning patients and the health care services provided to patients; downloadable software, downloadable software applications and downloadable mobile applications for providing co-pay information and estimates, providing access to secure medical documents, providing financial support services in the nature of payment processing; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable software, downloadable software applications and downloadable mobile applications for the measurement of height, weight, blood pressure, serum calcium, blood glucose, and heart rate; downloadable software, downloadable software applications and downloadable mobile applications for providing, exchanging, retrieving and analyzing health and healthcare information; downloadable software for medical purposes, namely, for formatting, viewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phones, tablet computers, handheld computers and personal computers, namely, a downloadable software application for providing healthcare-related information, medication reminders, and tracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidism, growth disorders, endocrine disorders and bone disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Oct 29, 2025 DP1B
NOTICE OF ALLOWANCE CANCELLED
Oct 29, 2025 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 27, 2025 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 13, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 21, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 16, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 16, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 16, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2024 CRFA
ASSIGNED TO LIE
Sep 24, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 22, 2023 NWOS
NEW APPLICATION ENTERED
May 25, 2023 NWAP